Deborah D. Ascheim, M.D. Elected to Longeveron Board of Directors
Longeveron elected Dr. Deborah D. Ascheim to its Board of Directors, adding a Chief Medical Officer with over 30 years of experience in gene and cell therapy. Dr.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.